ClinicalTrials.gov
public full text
Public Domain
Vascular Effects of SGLT2i in Non-diabetic CKD
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Performance Under SGLT-2-Inhibitors in Humans#1033010
- SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Comparative Review of Efficacy, Cardiovascular and Renal Benefits, and Cost#179740
- Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes#398295
- The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function#851602
- A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients#911294
Record · ID 184772
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive